Hypercalcemia as a biomarker of myeloproliferative neoplasms?
dc.contributor.author | Langabeer, Stephen E. | |
dc.date.accessioned | 2020-05-25T12:36:33Z | |
dc.date.available | 2020-05-25T12:36:33Z | |
dc.date.issued | 2019-09-03 | |
dc.identifier.issn | 1611-2156 | |
dc.identifier.uri | http://hdl.handle.net/2003/39126 | |
dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-21044 | |
dc.language.iso | en | |
dc.relation.ispartofseries | EXCLI Journal;Vol. 18. 2019, p.777-778 | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.ddc | 610 | |
dc.title | Hypercalcemia as a biomarker of myeloproliferative neoplasms? | en |
dc.type | Text | |
dc.type.publicationtype | article | |
dcterms.accessRights | open access | |
eldorado.dnb.zdberstkatid | 2132560-1 | |
eldorado.secondarypublication | true |